Invention Grant
- Patent Title: Fibrin gel for controlled release of PDGF and uses thereof
- Patent Title (中): 用于控释PDGF的纤维蛋白凝胶及其用途
-
Application No.: US13750403Application Date: 2013-01-25
-
Publication No.: US09012393B2Publication Date: 2015-04-21
- Inventor: Isabelle Catelas , Joseph Dwyer , Wanda Seyton , Shane Donovan , Sam L. Helgerson
- Applicant: Baxter International Inc. , Baxter Healthcare SA
- Applicant Address: US IL Deerfield CH Glattpark (Opfikon)
- Assignee: Baxter International Inc.,Baxter Healthcare SA
- Current Assignee: Baxter International Inc.,Baxter Healthcare SA
- Current Assignee Address: US IL Deerfield CH Glattpark (Opfikon)
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/18 ; A61K38/43 ; A61K38/46 ; C07K1/00 ; A61K35/14
Abstract:
The present invention relates, in general, to fibrin sealants, which contain platelet derived growth factor (PDGF) for controlled release in situ for therapeutic applications, including musculoskeletal disorders, soft tissue disorders and vascular diseases.
Public/Granted literature
- US20130143808A1 Fibrin Gel for Controlled Release of PDGF and Uses Thereof Public/Granted day:2013-06-06
Information query
IPC分类:
